Physical illness and mental illness are not related. T/F?
False. More than half of those with mental illness also have a chronic physical illness.
Etiology and pathophysiology of depression.
Primary cause:
Monoamine hypothesis: reduced number of neurotransmitters in brain (e.g. norepinephrine (NE), serotonin (5-HT), dopamine (DA)).
Secondary causes:
Endocrine disorders: hypothyroidism, T2DM in women
Cardioavascular: CAD, CHF, MI
Clinical presentation for MDD (In. SAD. CAGES)
o At least 5 symptoms have been present during the same 2-week period
o One of the symptoms must be depressed mood or lost of interest
Interest: decreased interest
Sleep: insomnia
Appetite: decreased appetite
Depressed: depressed mood
Concentration: impaired concentration and decision making
Activity: psychomotor retardation or agitation
Guilt: feelings of guilt or worthlessness
Energy: decreased energy or fatigue
Suicidal thoughts or attempts
o Symptoms cause significant distress or impairment in social, occupational or other important areas of functioning.
o Symptoms are not caused by an underlying medical condition or substance.
Assessments for depression
Clinician-rated
Self-rated:
- Screening tool: Patient Health Questionnaire (PHQ-2)
- Assessment tool: PHQ-9
Score above 5 to be considered depressed
Treatment principle
Combination of non-pharmacological and pharmacological treatment method
Non-pharmacological therapy for depression
- Psychotherapy
Pharmacological therapies (in general)
- First-line (antidepressant monotherapy): SSRI, SNRI, Mirtazapine or Bupropion
Types of TCAs
Amitriptyline, clomipramine, dothiepin, imipramine, nortriptyline
Types of SSRIs
Escitalopram, fluvoxamine, fluoxetine, paroxetine, sertraline, citalopram
Types of SNRIs
Venlafaxine, duloxetine
Type of SMS
Vortioxetine
Type of NaSSA
Mirtazapine
RIMA
Moclobemide
Others
Bupropion, trazodone, agomelatine
Other psychiatric indication in addition to depression
TCAs:
Types: Amitriptyline -> Nortriptyline Imipramine -> Desipramine Dothiepin Clomipramine
MOA:
Blocks reuptake of 5HT and NA
Side effects:
Notes:
- 2° amines (nortriptyline, desipramine) have lower anticholinergic, sedation and cardiotoxic side effects
Phases of treatment
SSRIs:
Types: Fluoxetine -> norfluoxetine Fluvoxamine Escitalopram Citalopram Paroxetine Sertraline
MOA:
Selective 5-HT antagonism
Side effects:
Notes:
SNRIs:
Types:
Venlafaxine -> desvenlafaxine
Duloxetine
MOA:
5 HT, NA antagonism
Side effects:
- Same as SSRI. Increased BP. Urinary incontinence (duloxetine)
SMS:
Type:
- Vortioxetine
MOA:
Side effects:
NaSSA:
Type:
- Mirtazapine
MOA:
Side effects:
- Somnolence, increased appetite, weight gain
Notes:
- Reverse GI and sexual side effects of SSRI/SNRI.
NDRI:
Type:
Bupropion
MOA:
- blocks uptake of NE and DA
Side effect:
- Seizure, not suitable for those with psychosis or eating disorders
Notes:
- Reduce sexual side effects of SSRI/SNRI.
MAOI:
Type: Moclobemide
- Reversible MAOi-A
Notes:
- Safest amongst MAOIs
Trazadone
MOA:
Side effects:
- Same as SSRI, sedation, orthostatic hypotension
Notes:
- Used for insomnia and depression